DRW Securities’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,587
Closed -$78.5K – 1444
2025
Q3
$78.5K Buy
+3,587
New +$86.5K ﹤0.01% 1203

Other funds holding MTRI

DRW Securities's MTRI Position: Q4 2025 in Review

DRW Securities sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2025, closing a stake of 3,587 shares — an estimated $78.5K sold.

DRW Securities first reported a position in MTRI in Q3 2025 and held it in 1 quarter. The position peaked at $78.5K in Q3 2025. 6 funds tracked by Wall St. Rank hold MTRI as of Q4 2025.

  • DRW Securities reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 3,587 Mentari Therapeutics, Inc. Common Stock shares in Q4 2025, an estimated $78.5K.
  • DRW Securities first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
  • DRW Securities's Mentari Therapeutics, Inc. Common Stock position peaked at $78.5K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.